HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, cilt.26, sa.1, ss.51-57, 2011 (SCI-Expanded)
Objective To investigate the comparative efficacy of aripiprazole and risperidone as augmenting agents in the treatment of obsessive-compulsive disorder (OCD) patients who did not show a >= 35% decrease in the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) after 12-week monotherapy with selective serotonin reuptake inhibitors (SSRIs).